20 Nov 2026, 11:53
Meetings & Governance—
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 20 Nov 2026, 11:53 | 2026 AGM Results of Meeting | Meetings & Governance | — | 08003 | |
| 20 Nov 2026, 09:25 | 2026 AGM presentation | Presentations | — | 03026, 15001 | |
| 20 Nov 2026, 09:22 | 2026 AGM Chair's Address to Shareholders | Presentations | — | 14014, 15002 | |
| 17 Nov 2026, 16:32 | AGM update - withdrawal of Brett Wells director resolution | Meetings & Governance | — | 08005 | |
| 17 Nov 2026, 09:25 | Investor presentation re Scheme with Gedeon Richter | Presentations | — | 03026 | |
| 17 Nov 2026, 09:13 | MYX enters Scheme Implementation Deed with Gedeon Richter | Mergers & Acquisitions | MS | 01012, 01015, 14014 | |
| 16 Nov 2026, 19:53 | AGM updates | Meetings & Governance | — | 08005 | |
| 6 Nov 2026, 08:53 | Investor presentation re International segment divestment | Presentations | — | 03026 | |
| 6 Nov 2026, 08:52 | Mayne Pharma to divest International segment for $55.5m | Mergers & Acquisitions | MS | 07002, 11001 | |
| 29 Oct 2026, 19:04 | Notification regarding unquoted securities - MYX | Securities Administration | — | 06021 | |
| 29 Oct 2026, 19:03 | Notification regarding unquoted securities - MYX | Securities Administration | — | 06021 | |
| 29 Oct 2026, 19:02 | Notification regarding unquoted securities - MYX | Securities Administration | — | 06021 | |
| 26 Oct 2026, 08:50 | Investor presentation | Presentations | — | 03026 | |
| 26 Oct 2026, 08:49 | Mayne Pharma reports unaudited Q1 FY27 results | Periodic Reports | MS | 03014 | |
| 19 Oct 2026, 09:15 | 2026 Notice of Annual General Meeting and shareholder pack | Presentations | — | 08001, 08004, 14014, 16002 | |
| 16 Oct 2026, 09:43 | MYX settles US patent litigation re Imvexxy with Teva USA | Company Update | MS | 11001 | |
| 14 Oct 2026, 13:29 | Supreme Court Decision in Cosette Proceedings | Company Administration | MS | 09014, 14003 | |
| 14 Oct 2026, 08:20 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 9 Oct 2026, 09:41 | Fulfilment of Imvexxy post-marketing study requirements | Company Update | — | 11001 | |
| 7 Oct 2026, 16:30 | Notification of cessation of securities - MYX | Securities Administration | — | 06027 | |
| 30 Sept 2026, 09:49 | MYX settles US patent litigation re Imvexxy with Sun Pharma | Company Update | MS | 11001, 14003 | |
| 28 Sept 2026, 09:45 | Mayne Pharma announces legal settlement | Company Administration | — | 12008, 14003 | |
| 28 Sept 2026, 09:42 | Date for Annual General Meeting | Meetings & Governance | — | 08006 | |
| 15 Sept 2026, 09:50 | MYX signs licence agreement for Blissel in Australia | Company Update | — | 11001 | |
| 8 Sept 2026, 18:42 | Notification of cessation of securities - MYX | Securities Administration | — | 06027 | |
| 8 Sept 2026, 18:41 | Notification regarding unquoted securities - MYX | Securities Administration | — | 06021 | |
| 28 Aug 2026, 17:29 | Application for quotation of securities - MYX | Securities Administration | — | 06020 | |
| 27 Aug 2026, 08:44 | 2026 Full Year Results Investor Presentation | Financial Results | — | 03003, 03026 | |
| 27 Aug 2026, 08:43 | 2026 Corporate Governance Statement and Appendix 4G | Company Administration | — | 03024, 03025 | |
| 27 Aug 2026, 08:42 | 2026 Full Year Results Media Release | Financial Results | MS | 03003, 14014 | |
| 27 Aug 2026, 08:40 | 2026 Appendix 4E and Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 21 Aug 2026, 12:56 | Notification of date for release of FY26 results | Presentations | — | 03027, 14014 | |
| 20 Aug 2026, 08:59 | Upcoming presentation of Imvexxy clinical data | Company Update | — | 11001 | |
| 18 Aug 2026, 09:16 | Mayne Pharma launches Investor Hub | Company Administration | — | 12008 | |
| 14 Aug 2026, 17:13 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 5 Aug 2026, 17:20 | Mayne Pharma Bioshares Summit Presentation | Presentations | — | 03026 | |
| 5 Aug 2026, 17:14 | Notification of cessation of securities - MYX | Securities Administration | — | 06027 | |
| 5 Aug 2026, 17:14 | Notification regarding unquoted securities - MYX | Securities Administration | — | 06021 | |
| 5 Aug 2026, 13:35 | Non-Executive Director appointment | Company Administration | — | 12001 | |
| 3 Aug 2026, 15:46 | Mayne Pharma to present at the 20th Bioshares Summit | Company Administration | — | 12008 | |
| 31 July 2026, 09:29 | Mayne Pharma reports unaudited Q4 and FY26 results | Periodic Reports | MS | 03014, 03027, 03028 | |
| 17 July 2026, 08:53 | Mayne Pharma appoints new Chief Financial Officer | Company Administration | — | 12008 | |
| 7 July 2026, 08:16 | Notification regarding unquoted securities - MYX | Securities Administration | — | 06021 | |
| 7 July 2026, 08:16 | Notification regarding unquoted securities - MYX | Securities Administration | — | 06021 | |
| 7 July 2026, 08:16 | Notification regarding unquoted securities - MYX | Securities Administration | — | 06021 | |
| 7 July 2026, 08:16 | Notification regarding unquoted securities - MYX | Securities Administration | — | 06021 | |
| 1 July 2026, 09:38 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 26 June 2026, 09:15 | Mayne Pharma appoints new Non-Executive Director | Company Administration | — | 12001 | |
| 26 June 2026, 09:11 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 18 June 2026, 14:57 | Change in substantial holding | Substantial Holders | — | 02002 |